The Clinical Investigation of Toothpaste as Compared to Toothpaste and Mouthwash in Reducing Plaque and Gingivitis: A Six-week Clinical Study in the US
- Conditions
- GingivitisDental Plaque
- Interventions
- Drug: Triclosan/fluoride toothpasteDrug: stannous fluoride toothpasteDrug: fluoride toothpasteDrug: Fluoride Mouthwash
- Registration Number
- NCT02360995
- Lead Sponsor
- Colgate Palmolive
- Brief Summary
The objective of this clinical research study is to evaluate clinical efficacy of Colgate Total Toothpaste as compared to Crest Pro-Health Toothpaste and Crest Pro-Health Mouthwash, and Crest Cavity Protection Toothpaste and Crest Fluoride Mouthwash in reducing gingivitis and dental plaque in adults in a six-week clinical study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 129
- Subjects, ages 18-70, inclusive.
- Availability for the six-week duration of the clinical research study.
- Good general health.
- Minimum of 20 uncrowned permanent natural teeth (excluding third molars).
- Initial gingivitis index of at least 1.0 as determined by the use of the Loe and Silness Gingival Index.
- Initial plaque index of at least 1.5 as determined by the use of the Quigley and Hein Plaque Index (Turesky Modification).
- Signed Informed Consent Form
- Presence of orthodontic bands.
- Presence of partial removable dentures.
- Tumor(s) of the soft or hard tissues of the oral cavity.
- Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone).
- Five or more carious lesions requiring immediate restorative treatment.
- Antibiotic use any time during the one month prior to entry into the study.
- Participation in any other clinical study or test panel within the one month prior to entry into the study.
- Dental prophylaxis during the past two weeks prior to baseline examinations.
- History of allergies to oral care/personal care consumer products or their ingredients.
- On any prescription medicines that might interfere with the study outcome.
- An existing medical condition which prohibits eating or drinking for periods up to 4 hours.
- History of alcohol or drug abuse.
- Pregnant or lactating subjects.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Total Toothpaste Triclosan/fluoride toothpaste Triclosan/fluoride toothpaste Toothpaste + Mouthwash stannous fluoride toothpaste Stannous fluoride toothpaste \& cetylpyridinium chloride Mouthwash Toothpaste + Mouthwash cetylpyridinium chloride Mouthwash Stannous fluoride toothpaste \& cetylpyridinium chloride Mouthwash Control group fluoride toothpaste fluoride toothpaste +fluoride mouthwash Control group Fluoride Mouthwash fluoride toothpaste +fluoride mouthwash
- Primary Outcome Measures
Name Time Method Dental Plaque Scores 6 weeks Dental Plaque (Quigley-Hein, Turesky Modification Index) Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)
Gingivitis Scores 6 weeks Gingivitis scale (Loe \& Silness Gingival Index) Units on a scale 0 to 3 (0 = no inflammation, 1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Loma Linda University
🇺🇸Loma Linda, California, United States